Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

New medicines: human

Get the latest updates from New medicines: human directly as they happen.

Follow now 398 followers

Latest posts

Last updated 14 days ago

Human medicines European public assessment report (EPAR): Fluad, influenza vaccine (surface antigen, inactivated, adjuvanted), Status: Opinion

14 days ago

Human medicines European public assessment report (EPAR): Fluad, influenza vaccine (surface antigen...

Human medicines European public assessment report (EPAR): Buprenorphine Neuraxpharm, buprenorphine, Status: Opinion

14 days ago

Human medicines European public assessment report (EPAR): Buprenorphine Neuraxpharm, buprenorphine, Status: Opinion

Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Status: Opinion

14 days ago

Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Status: Opinion

Human medicines European public assessment report (EPAR): Siiltibcy, rdESAT-6 / rCFP-10, Status: Opinion

14 days ago

Human medicines European public assessment report (EPAR): Siiltibcy, rdESAT-6 / rCFP-10, Status...

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Status: Opinion

14 days ago

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Status: Opinion

Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Status: Opinion

14 days ago

Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Status: Opinion

Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Status: Opinion

14 days ago

Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Status: Opinion

Human medicines European public assessment report (EPAR): Alhemo, concizumab, Status: Opinion

14 days ago

Human medicines European public assessment report (EPAR): Alhemo, concizumab, Status: Opinion

Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Status: Opinion

14 days ago

Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen...

Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Status: Opinion

14 days ago

Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Status: Opinion

Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Status: Opinion

Human medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Status: Opinion

about 1 month ago

Human medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Status: Opinion